Latest News

Keep up to date with the latest news from Pilatus Biosciences.

News

May 19, 2026

Pilatus Biosciences to Present Preclinical Data Highlighting Novel Metabolic Checkpoint Therapy PLT012 at EASL Congress 2026

May 5, 2026

Pilatus Biosciences Announces Formation of Scientific Advisory Board

April 8, 2026

Pilatus Biosciences to Present New Data Highlighting Sex-Specific Efficacy of CD36-Targeting Antibody in Colorectal Cancer at AACR 2026

March 12, 2026

Pilatus Biosciences Announces First Patient Dosed in Phase 1 Trial of First-in-Class Metabolic Checkpoint Antibody PLT012 in Solid Tumors

Upcoming Events

June 24, 2026

-

San Diego

BIO International Convention San Diego

More Info